It looks like you are visiting from outside the EU. Switch to the US version to see local pricing in USD and local shipping.

Switch to US ($)

Antibody-drug conjugates

  • Antibody-antibiotic conjugates for therapeutic applications

    Antibody-antibiotic conjugates for therapeutic applications

    Thomas Meyer Thomas Meyer 4 min read

    Antibody-antibiotic conjugates (AACs) are an emerging class of biotherapeutics for the treatment of infectious diseases. With the rise of antibiotic resistance, this new class of drugs is expected to gain…

  • Antibody-enzyme conjugates for therapeutic applications
    Antibody-drug conjugates

    Antibody-enzyme conjugates for therapeutic applications

    Antibody-enzyme conjugates represent a small but growing field of study within the vast topic of payloads for antibody-drug conjugate… Read More

  • Immunotoxins: protein toxins as payloads of ADCs
    Antibody-drug conjugates

    Immunotoxins: protein toxins as payloads of ADCs

    When conjugated to antibodies and used in combinatorial therapeutic applications, protein toxins are typically referred to as fusion proteins or… Read More

  • DNA-damaging agents and transcription inhibitors as payloads of ADCs
    Antibody-drug conjugates

    DNA-damaging agents and transcription inhibitors as payloads of ADCs

    DNA-damaging agents are one of the major classes of payloads used in antibody-drug conjugate (ADC) development. Unlike tubulin inhibitors, most… Read More

  • Linker technology for ADC generation
    Antibody-drug conjugates

    Linker technology for ADC generation

    Experts believe that most challenges tied to the production of ADCs can be overcome by creating better linkers for… Read More

  • Tubulin inhibitors as payloads of ADCs
    Antibody-drug conjugates

    Tubulin inhibitors as payloads of ADCs

    Payloads are the pharmaceutical component of antibody-drug conjugates (ADCs). Often these components are small drugs too toxic to be administered… Read More

  • ADC payloads
    Antibody-drug conjugates

    ADC payloads

    Antibody-drug conjugates (ADCs) are an emerging class of pharmaceuticals designed to deliver highly toxic cargoes (payloads) to clinical targets. Read More

  • Cleavable linkers for ADCs
    Antibody-drug conjugates

    Cleavable linkers for ADCs

    Cleavable linkers are a major class of linkers used in ADC development. As their name indicates, they have inbuilt… Read More

  • Non-cleavable linkers for ADCs
    Antibody-drug conjugates

    Non-cleavable linkers for ADCs

    Different linker chemistry approaches have been developed since the inception of ADCs. Currently, cleavable and non-cleavable linkers are the… Read More

  • How to choose the best linker for an ADC? Cleavable vs. non-cleavable
    Antibody-drug conjugates

    How to choose the best linker for an ADC? Cleavable vs. non-cleavable

    Antibody-drug conjugate linker chemistry has greatly evolved since the development of the first molecules. Linkers can be defined as… Read More

Cart (0 Items)

Your cart is currently empty.

View Products